Trusted Resource for Clinical Trials, Protocols & Progress
In the complex landscape of clinical trial logistics, the accurate identification of biological samples is a critical factor influencing data integrity, patient safety, and regulatory compliance. Traditional handwritten or manual labels are increasingly being replaced by barcode-based systems that improve efficiency, traceability, and standardization.
Click to read the full article.
The movement of clinical trial biospecimens—from site to central lab or biorepository—must be fully traceable to protect data integrity, subject safety, and regulatory compliance. The “chain of custody” ensures that each transfer of a biological sample is documented, authorized, and verifiable, minimizing the risk of tampering, loss, or misidentification.
Click to read the full article.
Maintaining the cold chain—the uninterrupted temperature-controlled transport and storage of biological samples—is critical in clinical trials involving pharmacokinetics, biomarkers, vaccines, and advanced therapies. Any deviation from defined temperature ranges may compromise sample viability and ultimately the scientific validity of trial data.
Click to read the full article.
In clinical research, the choice and qualification of couriers used for transporting clinical samples—especially temperature-sensitive and time-critical biological specimens—is increasingly scrutinized during regulatory inspections. FDA, EMA, and other global agencies consider couriers as “critical service providers” under GxP oversight obligations.
Click to read the full article.
Clinical trial samples, especially those containing biological substances, must be packaged in accordance with the International Air Transport Association (IATA) Dangerous Goods Regulations (DGR). Non-compliance can lead to sample rejection, customs delays, or regulatory inspection findings.
Click to read the full article.
Timely shipment of clinical trial samples is critical to preserving specimen viability, ensuring accurate lab analysis, and meeting protocol-defined windows. However, logistical disruptions—ranging from courier failures to customs holds—can lead to delays that compromise sample integrity and attract regulatory scrutiny.
Click to read the full article.
Accurate sample tracking is critical in clinical trials to ensure traceability, prevent loss or mislabeling, and maintain chain of custody from site to lab. Regulatory bodies like the FDA and EMA have increased focus on sample accountability, especially in trials involving biomarkers, genetic analysis, and pharmacokinetics.
Click to read the full article.
Clinical trial samples—such as serum, plasma, whole blood, and biopsies—are often temperature-sensitive. Maintaining their stability through validated cold chain processes is critical to preserving integrity and ensuring data reliability.
Click to read the full article.
As clinical trials expand across borders, the need for sample labels in multiple languages has become essential. Accurate and compliant labeling not only ensures sample traceability and safe transport but also meets the regulatory requirements of country-specific authorities. Incorrect or poorly translated labels can lead to customs rejections, site confusion, or sample mismanagement—each of which can result in regulatory findings.
Click to read the full article.
In clinical trials, ensuring that samples reach the designated laboratories in a timely, intact, and compliant manner is critical to maintaining data integrity. Poor planning, lack of SOP adherence, and incomplete documentation during transport have been repeatedly flagged by regulatory authorities like the FDA and EMA. A well-structured sample transport readiness checklist serves as a preventive control and a key document during inspections.
Click to read the full article.
